Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma
- PMID: 23079654
- DOI: 10.1016/j.ccr.2012.08.024
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma
Abstract
Glioblastoma (GBM) is a brain tumor that carries a dismal prognosis and displays considerable heterogeneity. We have recently identified recurrent H3F3A mutations affecting two critical amino acids (K27 and G34) of histone H3.3 in one-third of pediatric GBM. Here, we show that each H3F3A mutation defines an epigenetic subgroup of GBM with a distinct global methylation pattern, and that they are mutually exclusive with IDH1 mutations, which characterize a third mutation-defined subgroup. Three further epigenetic subgroups were enriched for hallmark genetic events of adult GBM and/or established transcriptomic signatures. We also demonstrate that the two H3F3A mutations give rise to GBMs in separate anatomic compartments, with differential regulation of transcription factors OLIG1, OLIG2, and FOXG1, possibly reflecting different cellular origins.
Copyright © 2012 Elsevier Inc. All rights reserved.
Comment in
-
Methylome alterations "mark" new therapeutic opportunities in glioblastoma.Cancer Cell. 2012 Oct 16;22(4):417-8. doi: 10.1016/j.ccr.2012.10.001. Cancer Cell. 2012. PMID: 23079650 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous